Obesity Drug Turns Arena Into Biggest Loser |
September 18, 2010 | September 2010 Bond Updates |
Shares plummet after FDA advisory committee votes against approval of lorcaserin weight loss drug. |
View more at: http://www.forbes.com/2010/09/17/todays-big-losers-arna-orex-mee-marketnewsvideo.html?feed=rss_markets |
Related News |
|